PIPELINE
Pipeline
Baobab AiBIO Pipeline
Drug Repositioning
New Chemical Entity
Large Molecule
Status | Program | Target Disease | Exploratory | Research | IND Enabling | Early Clinical | Late Clinical | Milestone/Issue |
---|---|---|---|---|---|---|---|---|
Active | BAB-104 | MSTO, GBM | IND in 4Q 2023 | |||||
BAB-107 | mCRC | in Vivo tool 4Q 2022 | ||||||
BAB-201 | Fibrosis | Collaboration | ||||||
BAB-202 | RA | Collaboration | ||||||
BAB-301 | Parkinson | Hit 2Q 2022 | ||||||
BAB-802 | Antibody | Collaboration | ||||||
BAB-803 | Fibrosis | Collaboration | ||||||
Basic Study |
BAB-103 | CRC, NSCLC | Properties improvement | |||||
BAB-105 | Breast Cancer | Collaboration | ||||||
BAB-106 | Cancer metastasis | Collaboration | ||||||
Undisclosed | immuno Oncology | structure 1Q 2022 | ||||||
Undisclosed | Fibrosis | structure 2Q 2022 |